Predictive value of symptoms for quality of life in first-episode schizophrenia

Nordic Journal of Psychiatry
Preeta Kaur ChughRavinder K Sah

Abstract

Management of the disease symptomatology impacts the long-term functioning and quality of life (QOL) in psychotic patients. The aim of this research was to study the association between psychiatric symptoms (positive, negative and general psychopathology symptoms) and QOL in first-episode schizophrenia patients. Fifty-five first-episode drug-naïve schizophrenia outpatients were recruited from a tertiary care hospital in New Delhi, India. WHOQOL-Bref (World Health Organization Quality of Life) Scale was used to assess multi-dimensional domains of QOL (physical, psychological, social and environmental health). The patients were evaluated clinically using PANSS and followed up for 6 months. Multivariate analyses were carried out to outline the symptoms which are predictive of QOL in these patients. Physical well-being as assessed with WHOQOL-Bref is significantly impacted by the positive, negative and general psychopathology symptoms of the disease. General psychopathology symptoms demonstrated a strong relationship with different facets of QOL. These symptoms are predictive of physical (P=0.025) and psychological health (P=0.026), social relationships (P=0.009) and environmental QOL (P=0.022). The general psychopathology symptoms...Continue Reading

References

Jan 1, 1992·Archives of General Psychiatry·T H McGlashan, W S Fenton
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1984·Schizophrenia Bulletin·D W HeinrichsW T Carpenter
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·P Kulhara
Feb 1, 1997·Social Psychiatry and Psychiatric Epidemiology·J P OliverW Kaiser
Nov 1, 1996·Acta Psychiatrica Scandinavica·I M WieselgrenL H Lindström
Aug 26, 1998·Acta Psychiatrica Scandinavica·F B DickersonF Parente
Aug 24, 2001·Schizophrenia Research·J D HuppertT E Smith
Apr 17, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S M SkevingtonUNKNOWN WHOQOL Group
Jun 10, 2005·The Australian and New Zealand Journal of Psychiatry·Signy WegenerJohn Brennan
Sep 13, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C W LawMolly S M Lo
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Alex HoferW Wolfgang Fleischhacker
Oct 15, 2005·Psychopathology·A KarowM Krausz
Dec 5, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·Hans-Helmut KönigMatthias C Angermeyer
Jan 6, 2007·Schizophrenia Bulletin·Shaun M Eack, Christina E Newhill
Feb 10, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Peter M WehmeierWolfgang Schreiber
Mar 24, 2007·Transcultural Psychiatry·A Bamiso MakanjuolaO Ayodele Obembe
Sep 11, 2007·The Australian and New Zealand Journal of Psychiatry·Amanda Wheeler
Oct 9, 2007·Schizophrenia Research·Jenille M NarvaezThomas L Patterson
Nov 1, 2008·Social Psychiatry and Psychiatric Epidemiology·Carin J MeijerAart H Schene

❮ Previous
Next ❯

Citations

May 3, 2014·The Psychiatric Quarterly·Aurigena Antunes de AraújoCaroline Addison Carvalho Xavier de Medeiros
Feb 26, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Mei San AngJimmy Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

European Psychiatry : the Journal of the Association of European Psychiatrists
J BobesM Bousoño
European Psychiatry : the Journal of the Association of European Psychiatrists
Gilles ReineChristophe Lancon
© 2021 Meta ULC. All rights reserved